XML 20 R5.htm IDEA: XBRL DOCUMENT v3.25.0.1
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Income Statement [Abstract]    
Product revenue $ 37,205 $ 2,065
Cost of goods sold (6,188) (635)
Gross profit 31,017 1,430
Operating expenses:    
Research and development expenses 13,874 17,502
Selling, general and administrative expenses 29,553 22,110
Total operating expenses 43,427 39,612
Operating loss (12,410) (38,182)
Change in fair value of warrant liability (14,071) (7,998)
Interest income (expense), net 125 (1,439)
Other expense (30) (59)
Net loss (26,386) (47,678)
Other comprehensive (loss) income:    
Unrealized gain on investments adjustments (22) 157
Foreign currency translation adjustments (31) 61
Total comprehensive loss $ (26,439) $ (47,460)
Common share data:    
Basic loss per common share (in dollars per share) $ (0.93) $ (2.94)
Diluted loss per common share (in dollars per share) $ (0.93) $ (2.94)
Weighted average number of basic shares outstanding (in shares) 28,511,393 16,229,931
Weighted average number of diluted shares outstanding (in shares) 28,511,393 16,229,931